Product Images Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound)
View Photos of Packaging, Labels & Appearance
- Slowly inject the 20 mL of 0.9% Sodium Chloride Injection, USP, over a minimum of 1 minute, using the sterile syringe to direct the solution flow onto the INSIDE WALL OF THE VIAL. - pacli 01
- Structural Formula for Paclitaxel - pacli 02
- Figure 1: Kaplan-Meier Curve of Overall Survival (Intent-to-Treat Population) - pacli 03
- PRINCIPAL DISPLAY PLAN - 100mg Vial - pacli 04
- PRINCIPAL DISPLAY PANEL - 100 mg Vial - pacli 05
- PRINCIPAL DISPLAY PANEL - 100 mg Vial Carton - pacli 06
- PRINCIPAL DISPLAY PANEL - 100 mg Vial Carton - pacli 07
Product Label Images
The following 7 images provide visual information about the product associated with Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) NDC 24979-710 by Upsher-smith Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Slowly inject the 20 mL of 0.9% Sodium Chloride Injection, USP, over a minimum of 1 minute, using the sterile syringe to direct the solution flow onto the INSIDE WALL OF THE VIAL. - pacli 01
Structural Formula for Paclitaxel - pacli 02
Figure 1: Kaplan-Meier Curve of Overall Survival (Intent-to-Treat Population) - pacli 03
PRINCIPAL DISPLAY PLAN - 100mg Vial - pacli 04
Paclitaxel protein-bound is a medication given in injectable suspension form containing albumin-bound particles. Each vial contains 100mg of the drug. The product is manufactured by Abraxane and has the National Drug Code of 24979-710-51. Dosage and administration instructions are not available.*
PRINCIPAL DISPLAY PANEL - 100 mg Vial - pacli 05
This is a description of a medication called "Pacitaxel Protein-Bound Particles for Injectable Suspension" with a strength of 100mg per vial. It is a type of albumin-bound medication used for treatment purposes. The text also mentions the name "Satsevi" and some unidentifiable numbers. The last line is unclear and the text overall is incomplete and difficult to interpret.*
PRINCIPAL DISPLAY PANEL - 100 mg Vial Carton - pacli 06
PRINCIPAL DISPLAY PANEL - 100 mg Vial Carton - pacli 07
This is a medication label for an injectable suspension called "Paclitaxel Protein-Bound." The package contains a vial with 100 mg of the suspension, which should be reconstituted with 20 mL of 0.9% Sodium Chloride Injection, USP. The suspension contains particles, is temperature-sensitive, and should be carefully read for instructions to avoid errors. The text also contains a lot of garbled characters, and the was not successful in decoding some parts of the label.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
